Health and Fitness Health and Fitness

Tue, April 30, 2013

[ Tue, Apr 30th 2013 ] - Market Wire

VentriPoint Receives Health Canada License for th .. RV(TM) Application for Non-Specific Heart Disease

[ Tue, Apr 30th 2013 ] - Market Wire

IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries

[ Tue, Apr 30th 2013 ] - Market Wire

ProMetic and Sartorius Stedim Biotech ("SSB") Joi .. nkey Solution for Producing Plasma-Derived Therap

Mon, April 29, 2013

[ Mon, Apr 29th 2013 ] - Market Wire

HeartWare International Reports $49.2 Million In .. ;; 87% Increase From First Quarter Of 2012

[ Mon, Apr 29th 2013 ] - Market Wire

Extendicare Announces Dividend Reduction to C$0.04 per Share

[ Mon, Apr 29th 2013 ] - Market Wire

Galapagos Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares

[ Mon, Apr 29th 2013 ] - Market Wire

Federman &;; Sherwood Announces That a .. it Has Been Filed Against Intuitive Surgical, Inc

[ Mon, Apr 29th 2013 ] - Market Wire

Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bayer HealthCare LLC

[ Mon, Apr 29th 2013 ] - Market Wire

Peregrine Announces Completion of Patient Enrollm .. t in Breast Cancer Clinical Trial for Bavituximab

[ Mon, Apr 29th 2013 ] - Market Wire

UK Hospitals Order All Varian TrueBeam Radiothera .. Systems Offered Under Government Stimulus Program

[ Mon, Apr 29th 2013 ] - Market Wire

Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies

[ Mon, Apr 29th 2013 ] - Market Wire

Alimera Sciences Announces ILUVIEN Now Available In U.K.

[ Mon, Apr 29th 2013 ] - Market Wire

Comprehensive Care Corporation Names Colonel Ramo .. ez President of CompCare Pharmacy Solutions, Inc.

[ Mon, Apr 29th 2013 ] - Market Wire

Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.

Sun, April 28, 2013

[ Sun, Apr 28th 2013 ] - Market Wire

Bayer to acquire Conceptus, Inc.

[ Sun, Apr 28th 2013 ] - Market Wire

Basilea reports presentation of new data on anti- .. ective drug candidates addressing drug resistance

Fri, April 26, 2013

[ Fri, Apr 26th 2013 ] - Market Wire

Sarepta Therapeutics to Announce First Quarter 20 .. ncial Results and Corporate Update on May 9, 2013

[ Fri, Apr 26th 2013 ] - Market Wire

Biologix Hair to Exhibit at 7th World Congress fo .. onal Investigative Dermatology Conference, Edinbu

[ Fri, Apr 26th 2013 ] - Market Wire

Actavis Announces OxyContin Patent Challenge Settlement

[ Fri, Apr 26th 2013 ] - Market Wire

Additional U.S. Patents for Lead Cancer Drug Cand .. engthen Critical Outcome's Investment Proposition

[ Fri, Apr 26th 2013 ] - Market Wire

SpectraScience Rescheduling Workshops Due to High Demand

[ Fri, Apr 26th 2013 ] - Market Wire

Masimo Steps Up with March for Babiesa" to Fight for Healthier Newborns

[ Fri, Apr 26th 2013 ] - Market Wire

DIFICID (fidaxomicin) Tablets Approved in Australia

[ Fri, Apr 26th 2013 ] - Market Wire

Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe

[ Fri, Apr 26th 2013 ] - Market Wire

Digirad Urges Stockholders to Vote the WHITE Proxy Card to Support Digirad's Director Nominees

[ Fri, Apr 26th 2013 ] - Market Wire

Ketchikan Medical Center Implements The SurgiCount Safety-Sponge System

[ Fri, Apr 26th 2013 ] - Market Wire

Simcere Pharmaceutical Group to Announce First Qu .. r 2013 Financial Results on Thursday, May 9, 2013

Thu, April 25, 2013

[ Thu, Apr 25th 2013 ] - Market Wire

NxStage Names Robert G. Funari Chairman Of The Board

[ Thu, Apr 25th 2013 ] - Market Wire

ResMed Inc. Announces Record Financial Results Fo .. uarter Ended And Nine Months Ended March 31, 2013

[ Thu, Apr 25th 2013 ] - Market Wire

Star Scientific Announces Registration Approval f .. y, HFL Sport Science, for Anatabloc Dietary Suppl

[ Thu, Apr 25th 2013 ] - Market Wire

Leisureworld Closes Previously Announced Public O .. pts and Extendible Convertible Unsecured Subordin

[ Thu, Apr 25th 2013 ] - Market Wire

Vycor Adds Two Patents for Its New Spinal ViewSite(TM) Cervical Access System

[ Thu, Apr 25th 2013 ] - Market Wire

ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment

[ Thu, Apr 25th 2013 ] - Market Wire

Ampio Pharmaceuticals Completes Enrollment in Run .. ING study of Ampion in Osteoarthritis of the Knee

[ Thu, Apr 25th 2013 ] - Market Wire

Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call

[ Thu, Apr 25th 2013 ] - Market Wire

VentriPoint Receives Request for Clarification to .. k) Submission for Pulmonary Arterial Hypertension

[ Thu, Apr 25th 2013 ] - Market Wire

Threshold Pharmaceuticals Announces Presentation .. at the 12th Annual Needham Healthcare Conference

[ Thu, Apr 25th 2013 ] - Market Wire

3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

Wed, April 24, 2013

[ Wed, Apr 24th 2013 ] - Market Wire

Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign

[ Wed, Apr 24th 2013 ] - Market Wire

Life Care Medical Devices Ltd Announces CE Mark A .. ialization For Laparoscopic Surgery Access Device

[ Wed, Apr 24th 2013 ] - Market Wire

Biologix Hair Inc. Appoints Dr. Arthur G. Handal to Medical Advisory Board

[ Wed, Apr 24th 2013 ] - Market Wire

3SBio Inc. Enters Into Amendment to Merger Agreem .. ot;;Going Privatequot;; Transaction

[ Wed, Apr 24th 2013 ] - Market Wire

Gentiva Health Services Schedules First Quarter 2 .. rnings Call And Webcast For Thursday, May 9, 2013

[ Wed, Apr 24th 2013 ] - Market Wire

Paladin Labs Announces the Canadian Launch of AmnioSense(TM)

[ Wed, Apr 24th 2013 ] - Market Wire

Trimel Pharmaceuticals Corporation Completes $40 Million Equity Financing

[ Wed, Apr 24th 2013 ] - Market Wire

Top-line Data Show AcelRx Pharmaceuticals' ARX-04 .. y Endpoint in Dose-Finding Phase 2 Clinical Trial

[ Wed, Apr 24th 2013 ] - Market Wire

STATS ChipPAC Appoints James A. Norling as Chairman

[ Wed, Apr 24th 2013 ] - Market Wire

Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment

[ Wed, Apr 24th 2013 ] - Market Wire

Omeros to Present at the 12th Annual Needham Healthcare Conference

Tue, April 23, 2013

[ Tue, Apr 23rd 2013 ] - Market Wire

AMRI and Ono Broaden SMARTSOURCINGa" Collaboration

[ Tue, Apr 23rd 2013 ] - Market Wire

MannKind, Ariad Pharma, Ziopharm Oncology, Galena .. opharma, and Novavax Under StockCall's Microscope

[ Tue, Apr 23rd 2013 ] - Market Wire

Celsion Corporation Provides Business Update

[ Tue, Apr 23rd 2013 ] - Market Wire

ISIS Pharmaceuticals Initiates a Clinical Study o .. IS-SMN Rx in Infants With Spinal Muscular Atrophy

[ Tue, Apr 23rd 2013 ] - Market Wire

Summit NW Selects Implant Sciences' QS-B220 Trace Detection System for Air Cargo Screening

[ Tue, Apr 23rd 2013 ] - Market Wire

Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs

[ Tue, Apr 23rd 2013 ] - Market Wire

New Data from AbbVie's Phase IIb Aviator Trial De .. l Response Rates Across Multiple Patient Types wi

[ Tue, Apr 23rd 2013 ] - Market Wire

Alchemia Announces Multi-Target Drug Discovery Co .. ation With AstraZeneca on VAST Discovery Platform

[ Tue, Apr 23rd 2013 ] - Market Wire

Ion Protona" de Life Technologies impulsa Stratified Medicine Scotland Innovation Centre

[ Tue, Apr 23rd 2013 ] - Market Wire

Ion Protona" da Life Technologies vai sustentar o Stratified Medicine Scotland Innovation Centre

[ Tue, Apr 23rd 2013 ] - Market Wire

Life Technologies' Ion Protona" to Power Stratified Medicine Scotland Innovation Centre

Mon, April 22, 2013

[ Mon, Apr 22nd 2013 ] - Market Wire

Galapagos starts Phase 2A study with GLPG0974 in ulcerative colitis

[ Mon, Apr 22nd 2013 ] - Market Wire

Lifshitz Law Firm Announces Investigation of Anar .. Life Technologies Corporation and National Finan

[ Mon, Apr 22nd 2013 ] - Market Wire

MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market

[ Mon, Apr 22nd 2013 ] - Market Wire

IMRIS to exhibit novel state-of-the-art VISIUS iCT imaging solution at AANS

[ Mon, Apr 22nd 2013 ] - Market Wire

Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund

[ Mon, Apr 22nd 2013 ] - Market Wire

Cheaper Gas, Airfare, Profits on Way as Commoditi .. s? - Top Small Cap Stock Focus Ahead of the Bell:

[ Mon, Apr 22nd 2013 ] - Market Wire

VentriPoint Announces Closing of Offering

[ Mon, Apr 22nd 2013 ] - Market Wire

Implant Sciences' Quantum Sniffer Explosives and .. to Be Exhibited at 11th Annual Expo Seguridad Me

[ Mon, Apr 22nd 2013 ] - Market Wire

Novadaq to Release First Quarter 2013 Financial R .. sults On April 29, 2013-Conference Call to Follow

[ Mon, Apr 22nd 2013 ] - Market Wire

GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan

Sun, April 21, 2013

[ Sun, Apr 21st 2013 ] - Market Wire

Galapagos discovers novel candidate drug to treat breast cancer

Fri, April 19, 2013

[ Fri, Apr 19th 2013 ] - Market Wire

Red Oak Partners Issues Open Letter to Digirad Co .. tion Shareholders About the Current Proxy Contest

[ Fri, Apr 19th 2013 ] - Market Wire

Ceregene Reports Data From Parkinson's Disease Phase 2b Study

[ Fri, Apr 19th 2013 ] - Market Wire

Novo Nordisk Unveils New U.S. Headquarters

[ Fri, Apr 19th 2013 ] - Market Wire

CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals

[ Fri, Apr 19th 2013 ] - Market Wire

Ceapro Reports Full-Year 2012 Financial and Operating Results

[ Fri, Apr 19th 2013 ] - Market Wire

BioScrip Prices Underwritten Offering of Common Stock

[ Fri, Apr 19th 2013 ] - Market Wire

iTech Medical, Inc. Enters Into Letter of Intent .. tal Ventures Inc. in Respect of a Proposed Merger

[ Fri, Apr 19th 2013 ] - Market Wire

Varian Medical Systems and Paul Scherrer Institut .. ounce Collaboration on Motion Management for IMPT

[ Fri, Apr 19th 2013 ] - Market Wire

Interim PILLAR II Results Reported During SAGES

[ Fri, Apr 19th 2013 ] - Market Wire

Omeros to Present Additional OMS302 Clinical Data .. the Annual ASCRS and ASOA Symposium and Congress

Thu, April 18, 2013

[ Thu, Apr 18th 2013 ] - Market Wire

La Jolla Pharmaceutical Company Receives Orphan Designation From FDA for LJPC-6417

[ Thu, Apr 18th 2013 ] - Market Wire

NW Bio Announces $10 Million Registered Direct Offering

[ Thu, Apr 18th 2013 ] - Market Wire

NW Bio Announces That Another Brain Cancer Patien .. rials Has Surpassed Ten-Year Cancer-Free Survival

[ Thu, Apr 18th 2013 ] - Market Wire

Unilife Develops Unifill Assurea" to Enhance Patient Self-Injection of Biologics

[ Thu, Apr 18th 2013 ] - Market Wire

UMeWorld New Trading Symbol "UMEWF" to Be Effective From April 18, 2013

[ Thu, Apr 18th 2013 ] - Market Wire

BD Anuncia Aprovao FDA 510(k) e Lanamento Comercial do BD UltraSafe PLUSa" Passive Needle Guard

[ Thu, Apr 18th 2013 ] - Market Wire

Accuray Provides Clarification on Recently Initiated Voluntary Recalls

[ Thu, Apr 18th 2013 ] - Market Wire

Implant Sciences Showcases Its Explosive Trace De .. ection Equipment at Counter Terror Expo in London

[ Thu, Apr 18th 2013 ] - Market Wire

United Therapeutics Corporation To Announce First .. ts Before Market Open On Thursday, April 25, 2013

[ Thu, Apr 18th 2013 ] - Market Wire

Un estudio publicado en European Radiology apoya el uso de la tomosntesis de mama de Hologic

Wed, April 17, 2013

[ Wed, Apr 17th 2013 ] - Market Wire

Cantel Medical To Present At Needham 12th Annual Healthcare Conference

[ Wed, Apr 17th 2013 ] - Market Wire

Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope

[ Wed, Apr 17th 2013 ] - Market Wire

Syneron Medical Appoints Co-Founder and Chairman .. Board Shimon Eckhouse to Chief Executive Officer

[ Wed, Apr 17th 2013 ] - Market Wire

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program

[ Wed, Apr 17th 2013 ] - Market Wire

VentriPoint Receives CE Mark for Major Expansion of Its VMST Platform for Right Heart Analysis

[ Wed, Apr 17th 2013 ] - Market Wire

Lorus Therapeutics Signs Research and License Option Agreement with Elanco

[ Wed, Apr 17th 2013 ] - Market Wire

Quest Diagnostics to Acquire Lab-Related Clinical .. ations of Dignity Health in California and Nevada

[ Wed, Apr 17th 2013 ] - Market Wire

CML HealthCare Inc. Appoints Chief Medical Officer

[ Wed, Apr 17th 2013 ] - Market Wire

Almirall und Forest Laboratories geben positive R .. zur Kombination von Aclidinium und Formoterol be

[ Wed, Apr 17th 2013 ] - Market Wire

Almirall e Forest Laboratories annunciano i risul .. i fase III per la combinazione aclidinium e formo

Tue, April 16, 2013

[ Tue, Apr 16th 2013 ] - Market Wire

BioScrip Announces Proposed Refinancing of Existing Indebtedness

[ Tue, Apr 16th 2013 ] - Market Wire

BioScrip Announces Proposed Public Offering of Common Stock

[ Tue, Apr 16th 2013 ] - Market Wire

Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development

[ Tue, Apr 16th 2013 ] - Market Wire

Critical Outcome Technologies Inc. Strengthens Investor Communications

[ Tue, Apr 16th 2013 ] - Market Wire

Cynosure To Host First-Quarter 2013 Financial Results Conference Call On April 30

[ Tue, Apr 16th 2013 ] - Market Wire

NW Bio's Phase III Trial With DCVax-L For Brain C .. dquot;; As A National Priority Trial In UK

[ Tue, Apr 16th 2013 ] - Market Wire

Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes

[ Tue, Apr 16th 2013 ] - Market Wire

Immunovaccine Receives Financial Contribution fro .. Provide Support Towards Clinical Studies in Comm

[ Tue, Apr 16th 2013 ] - Market Wire

Sequenom CMM Achieves Milestone Of 100,000 MaterniT21a" Plus Tests Processed

[ Tue, Apr 16th 2013 ] - Market Wire

DURECT Announces Submission of New Drug Application for POSIDURa" (SABER-Bupivacaine)

Mon, April 15, 2013

[ Mon, Apr 15th 2013 ] - Market Wire

Endo to Announce First Quarter 2013 Financial Results on May 7, 2013

[ Mon, Apr 15th 2013 ] - Market Wire

Star Scientific's Anatabloc Brand Ambassadors, Fr .. ples and John Isner, Shine at Weekend Tournaments

[ Mon, Apr 15th 2013 ] - Market Wire

Biologix Hair Inc. Retains Akerman Senterfitt;; Company to Pursue NYSE Market Listing

[ Mon, Apr 15th 2013 ] - Market Wire

Bernstein Liebhard LLP Announces Investigation Of Acquisition By Thermo Fisher Scientific

[ Mon, Apr 15th 2013 ] - Market Wire

IsoRay on Display at the American Brachytherapy S .. eaturing Its Cesium-131 Cancer Fighting Portfolio

[ Mon, Apr 15th 2013 ] - Market Wire

Vycor Launches New Extension Arm for Its Patented ViewSite(TM) Brain Access System (VBAS)

[ Mon, Apr 15th 2013 ] - Market Wire

Med BioGene Announces Date of Annual and Special Meeting

[ Mon, Apr 15th 2013 ] - Market Wire

SeeThruEquity Initiates Coverage on Milestone Scientific

[ Mon, Apr 15th 2013 ] - Market Wire

Royalty Pharma Announces Firm Offer to Acquire Elan

[ Mon, Apr 15th 2013 ] - Market Wire

Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States

Fri, April 12, 2013

[ Fri, Apr 12th 2013 ] - Market Wire

Quick-Med Engages Match Point Partners as Financial Advisor

[ Fri, Apr 12th 2013 ] - Market Wire

Gestion notify of 4.97% shareholding in Galapagos

[ Fri, Apr 12th 2013 ] - Market Wire

Boston Scientific Launches Precision Spectraa" Spinal Cord Stimulator System In The United States

[ Fri, Apr 12th 2013 ] - Market Wire

Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor

[ Fri, Apr 12th 2013 ] - Market Wire

Pre-Market Analysis on Life Technologies, Quest D .. Senior Living, Antares Pharma, and Optimer Pharma

[ Fri, Apr 12th 2013 ] - Market Wire

HCA Holdings, Tenet Healthcare, Health Management .. rsal Health Services Under StockCall's Microscope

[ Fri, Apr 12th 2013 ] - Market Wire

Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma

[ Fri, Apr 12th 2013 ] - Market Wire

ProMetic Begins Trading on OTCQX(R)

Thu, April 11, 2013

[ Thu, Apr 11th 2013 ] - Market Wire

Regeneron to Report First Quarter 2013 Financial .. d Host Conference Call and Webcast on May 3, 2013

[ Thu, Apr 11th 2013 ] - Market Wire

MiMedx to Present at Regen Med Investor Day 2013

[ Thu, Apr 11th 2013 ] - Market Wire

Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares

[ Thu, Apr 11th 2013 ] - Market Wire

Biologix Hair Inc. Announces Upward Revisions to Initially Reported Clinician Licensing Numbers

[ Thu, Apr 11th 2013 ] - Market Wire

Sarepta Therapeutics and University of Western Au .. rldwide Licensing Agreement for Exon-Skipping Pro

[ Thu, Apr 11th 2013 ] - Market Wire

BIOLASE Engages Porter, LeVay &;; Rose, Inc. for Investor Relations

[ Thu, Apr 11th 2013 ] - Market Wire

[ Thu, Apr 11th 2013 ] - Market Wire

AtheroNova Adds New Medical Advisor

[ Thu, Apr 11th 2013 ] - Market Wire

Boston Therapeutics Requests an IND Meeting With .. uce Postprandial Hyperglycemia in Type 2 Diabetes

[ Thu, Apr 11th 2013 ] - Market Wire

Pharmacyclics Triggers Fourth Milestone Payment f .. t of 5th Patient in Frontline Phase III CLL Study

Wed, April 10, 2013

[ Wed, Apr 10th 2013 ] - Market Wire

Sangamo BioSciences Announces Presentation At Regen Med Investor Day

[ Wed, Apr 10th 2013 ] - Market Wire

MEI Pharma's Mitochondrial Inhibitor Drug Candida .. ys Tumor Growth In Recurrent Ovarian Cancer Model

[ Wed, Apr 10th 2013 ] - Market Wire

Sirona Biochem Renews Corporate Development Contract with Ray Matthews and Associates

[ Wed, Apr 10th 2013 ] - Market Wire

Rotech Receives Approval of First Day Motions; .. 59; Approvals Ensure Operations Continue Normally

[ Wed, Apr 10th 2013 ] - Market Wire

Data Presented at AACR Annual Meeting Support Tar .. hanism and Potential of Peregrine's Bavituximab i

[ Wed, Apr 10th 2013 ] - Market Wire

USANA Receives More Than 20 Awards During First Quarter

[ Wed, Apr 10th 2013 ] - Market Wire

Extendicare Announces 2013 First Quarter Financia .. e, Conference Call and Annual Meeting Information

[ Wed, Apr 10th 2013 ] - Market Wire

Stocks Move Higher as Apple May Release New iPhone in Up to Three Different Sizes

[ Wed, Apr 10th 2013 ] - Market Wire

Aeterna Zentaris and Ergomed Sign Co-Development .. ring Agreement for AEZS-108 in Endometrial Cancer

[ Wed, Apr 10th 2013 ] - Market Wire

Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis

Tue, April 9, 2013

[ Tue, Apr 09th 2013 ] - Market Wire

Canada's Largest Automated Hematology System is Now Live at CML HealthCare Inc.

[ Tue, Apr 09th 2013 ] - Market Wire

Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options

[ Tue, Apr 09th 2013 ] - Market Wire

Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS

[ Tue, Apr 09th 2013 ] - Market Wire

POZEN to Host Analyst and Investor Update Webcast

[ Tue, Apr 09th 2013 ] - Market Wire

Critical Outcome Technologies Inc. Provides Important Update on AML Program

[ Tue, Apr 09th 2013 ] - Market Wire

CardioGuide System Enables Real-Time Navigation o .. t Ventricular Leads During Medtronic CRT Implants

[ Tue, Apr 09th 2013 ] - Market Wire

DiagnoCure's adoption of an advance notice policy

[ Tue, Apr 09th 2013 ] - Market Wire

Theratechnologies Board of Directors Appoints Former Merck Canada President

[ Tue, Apr 09th 2013 ] - Market Wire

[ Tue, Apr 09th 2013 ] - Market Wire

Research shows that superbugs are killed by ACTICOATa" silver-coated antimicrobial dressings

Mon, April 8, 2013

[ Mon, Apr 08th 2013 ] - Market Wire

OriGene to Acquire SDIX's Life Science Business Assets

[ Mon, Apr 08th 2013 ] - Market Wire

DiaMedica Receives Phase I/II Clinical Trial Regu .. for DM-199 as a Potential Treatment for Diabetes

[ Mon, Apr 08th 2013 ] - Market Wire

CryoLife To Host Central Venous Pathology Summit

[ Mon, Apr 08th 2013 ] - Market Wire

French National Television Newscast Highlights En .. ring Hansen Medical's Magellan(TM) Robotic System

[ Mon, Apr 08th 2013 ] - Market Wire

Boston Therapeutics Featured in Four Publications

[ Mon, Apr 08th 2013 ] - Market Wire

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products

[ Mon, Apr 08th 2013 ] - Market Wire

Theratechnologies Announces Termination of Agreement With Ferrer

[ Mon, Apr 08th 2013 ] - Market Wire

NewLink Genetics Presents Preclinical Data on New .. ay Inhibitor, NLG919, at AACR 2013 Annual Meeting

[ Mon, Apr 08th 2013 ] - Market Wire

Pharmacyclics Announces Third Breakthrough Therap .. utinib from the U.S. Food and Drug Administration

[ Mon, Apr 08th 2013 ] - Market Wire

SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm

Sat, April 6, 2013

[ Sat, Apr 06th 2013 ] - Market Wire

GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D

Fri, April 5, 2013

[ Fri, Apr 05th 2013 ] - Market Wire

Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call

[ Fri, Apr 05th 2013 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. n Their Investment in Incyte Corporation of Class

[ Fri, Apr 05th 2013 ] - Market Wire

East Tennessee Children's Hospital Installs Masim .. for Improved Oversight of Postoperative Patients

[ Fri, Apr 05th 2013 ] - Market Wire

TPI Targets Qionglai Facility (QLF) Construction Completion in Mid April

[ Fri, Apr 05th 2013 ] - Market Wire

GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D

[ Fri, Apr 05th 2013 ] - Market Wire

Uroplasty Announces CEO Resignation

[ Fri, Apr 05th 2013 ] - Market Wire

Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases

[ Fri, Apr 05th 2013 ] - Market Wire

Trimel Pharmaceuticals Corporation Announces Upda .. Milestone Payment and Amendment to Loan Agreement

[ Fri, Apr 05th 2013 ] - Market Wire

MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock

[ Fri, Apr 05th 2013 ] - Market Wire

EntreMed Announces Changes to Board of Directors and CEO Appointment

Thu, April 4, 2013

[ Thu, Apr 04th 2013 ] - Market Wire

Pharmagen Presents to North Carolina General Assembly at N.C. Bio's Legislative Breakfast

[ Thu, Apr 04th 2013 ] - Market Wire

Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.;; Price Target $3.50

[ Thu, Apr 04th 2013 ] - Market Wire

Syneron lanza la tecnologa exclusiva Sublative para cicatrices de acn

[ Thu, Apr 04th 2013 ] - Market Wire

BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare

[ Thu, Apr 04th 2013 ] - Market Wire

Turning Atlanta into America's Next Silicon Valley

[ Thu, Apr 04th 2013 ] - Market Wire

CryoLife Receives FDA Clearance For Next Generation HeRO Device

[ Thu, Apr 04th 2013 ] - Market Wire

Array BioPharma Announces Updates on ARRY-520 Cli .. l Data at the 2013 International Myeloma Workshop

[ Thu, Apr 04th 2013 ] - Market Wire

Life Technologies Launches Oncomine Bioinformatics Solutions for Cancer Researchers

[ Thu, Apr 04th 2013 ] - Market Wire

CEL-SCI's Price Rebound Looks Strong

[ Thu, Apr 04th 2013 ] - Market Wire

VolitionRx Files Two Patent Applications

Wed, April 3, 2013

[ Wed, Apr 03rd 2013 ] - Market Wire

Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer

[ Wed, Apr 03rd 2013 ] - Market Wire

Generex Comments on Results of Stockholders' Meeting

[ Wed, Apr 03rd 2013 ] - Market Wire

Biologix Hair to Exhibit at the 11th Annual Anti- .. g Medicine World Congress, Grimaldi Forum, Monaco

[ Wed, Apr 03rd 2013 ] - Market Wire

Bioassociate Announces Valuation Report on RedHill Biopharma, Ltd.

[ Wed, Apr 03rd 2013 ] - Market Wire

Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference

[ Wed, Apr 03rd 2013 ] - Market Wire

La Jolla Pharmaceutical Announces Start of Common Stock Quotation on OTCBB

[ Wed, Apr 03rd 2013 ] - Market Wire

DARA BioSciences Enters Into Distribution Agreeme .. mox(R) With Prime Therapeutics Specialty Pharmacy

[ Wed, Apr 03rd 2013 ] - Market Wire

Oramed Pharmaceuticals Granted Japanese Patent fo .. its Core Technology in Oral Delivery of Proteins

[ Wed, Apr 03rd 2013 ] - Market Wire

Renegotiated Lease to Generate Substantial Annual Savings

[ Wed, Apr 03rd 2013 ] - Market Wire

Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis

Trading in Theravance Common Stock Halted

_{//health-fitness.news-articles.net/content/2013/ .. 7/trading-in-theravance-common-stock-halted.html}
^{Published in Health and Fitness on Wednesday, April 17th 2013 at 4:17 GMT by Market Wire}

April 17, 2013 07:05 ET

Trading in Theravance Common Stock Halted

FDA Advisory Committee to Review BREO™ ELLIPTA™ NDA

SOUTH SAN FRANCISCO, CA--(Marketwired - Apr 17, 2013) - Theravance, Inc. (NASDAQ: [ THRX ]) today announced that NASDAQ halted trading of Theravance common stock this morning, April 17, 2013. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) meets today to discuss the new drug application (NDA) 204275, for fluticasone furoate (FF) and vilanterol (VI) dry powder inhaler (proposed trade name BREO™ ELLIPTA™), sponsored by GlaxoSmithKline plc (GSK), for the long-term maintenance treatment of airflow obstruction and for reducing exacerbations in patients with chronic obstructive pulmonary disease. FF/VI, an investigational once-daily inhaled corticosteroid/long-acting beta₂ agonist (LABA) combination treatment, is in development under the LABA collaboration between GSK and Theravance, Inc.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Theravance's key programs include: RELVAR™ or BREO™ ELLIPTA™ (FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta₂Agonist), each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. For more information, please visit Theravance's web site at [ www.theravance.com ].

THERAVANCE®, the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of Theravance, Inc.

RELVAR™ or BREO™ ELLIPTA™ (FF/VI) and ANORO™ ELLIPTA™ (UMEC/VI) are investigational medicines and are not currently approved anywhere in the world. RELVAR™, BREO™, ANORO™ and ELLIPTA™ are trademarks of the GlaxoSmithKline group of companies. The use of these brand names has not yet been approved by any regulatory authority.

(THRX-G)

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire